Everence Capital Management’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-21,810
Closed -$455K 818
2022
Q3
$455K Hold
21,810
0.04% 374
2022
Q2
$453K Hold
21,810
0.04% 377
2022
Q1
$366K Hold
21,810
0.03% 501
2021
Q4
$436K Hold
21,810
0.03% 468
2021
Q3
$396K Buy
21,810
+7,160
+49% +$164K 0.03% 474
2021
Q2
$396K Hold
14,650
0.03% 474
2021
Q1
$439K Sell
14,650
-3,690
-20% -$126K 0.04% 420
2020
Q4
$527K Hold
18,340
0.05% 328
2020
Q3
$447K Hold
18,340
0.05% 330
2020
Q2
$280K Hold
18,340
0.03% 476
2020
Q1
$149K Buy
18,340
+4,360
+31% +$49.8K 0.02% 553
2019
Q4
$185K Buy
+13,980
New +$169K 0.03% 628

Other funds holding CVET

Everence Capital Management's CVET Position: Q4 2022 in Review

Everence Capital Management sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 21,810 shares — an estimated $455K sold.

Everence Capital Management first reported a position in CVET in Q4 2019 and held it in 12 quarters. The position peaked at $527K in Q4 2020. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Everence Capital Management reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Everence Capital Management sold 21,810 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $455K.
  • Everence Capital Management first reported a position in Covetrus, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • Everence Capital Management's Covetrus, Inc. Common Stock position peaked at $527K in Q4 2020.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Everence Capital Management's 13F filing for Q4 2022, filed 31 Jan 2023.